FDA Import Refusal 799-0061604-7/11/1 — Novartis Pharmaceuticals Canada Inc.
The FDA refused shipment 799-0061604-7/11/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Apr 24, 2024. The refused product falls under Drugs and Biologics — OMALIZUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Apr 24, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58ACK04 OMALIZUMAB
- Charges
- 75